Clinical Trial Update: A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and antiviral effect of ABT-450/ritonavir and ABT-530 with and without ribavirin in adults with genotype 3 hepatitis C; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ABT-450/ritonavir (paritaprevir/ritonavir)
• ABT-530
• Ribavirin (ribavirin)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C, Hepatitis C Virus | Phase 2 | Status: COMPLETED | Results posted: 2017-02-02